Clinical trials
Phase 2 trials in Singapore with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
72 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 12 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 72 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National University Hospital, Singapore | 44 |
| National Cancer Centre, Singapore | 7 |
| Singapore General Hospital | 6 |
| KK Women's and Children's Hospital | 2 |
| Tan Tock Seng Hospital | 2 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| Commonwealth Scientific and Industrial Research Organisation, Australia | 1 |
| HCA Hospice Care | 1 |
| National Heart Centre Singapore | 1 |
| National Skin Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 11 |
| Stomach Neoplasms | 6 |
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Head and Neck Neoplasms | 3 |
| Liver Neoplasms | 3 |
| Bites and Stings | 2 |
| Carcinoma, Hepatocellular | 2 |
| Multiple Myeloma | 2 |
| Neoplasms, Plasma Cell | 2 |
Trials
Showing 1 to 25 of 72. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.